Shares of Sodastream International rose more than 6 percent Tuesday after it debuted a device for making homemade beer. » Read More
Amit Daryanani on Tuesday cast some doubt on a report that says Apple will take longer to roll out substantial iPhone updates.
The relationship between stocks and bonds merits close attention, according to technically minded trader Todd Gordon.
Financials have been on a tear lately, and the party is likely to keep going, RBC analyst Gerard Cassidy says.
Shares of one little-watched stock have skyrocketed over the past five years. Here's why traders and analysts say it still has room to run.
Shares of Coca-Cola European Partners, formerly Coca-Cola Enterprises, rose more than 4.5 percent.
Wall Street seems to be growing more comfortable with the possibility of Donald Trump winning the presidential election.
Medtronic shares dipped nearly 2 percent despite posting quarterly results that beat analyst expectations.
Biotech has been at a low year-to-date, but traders believe the sector is going to make a comeback.
Forget about the Fed. Stocks are poised for double-digit returns this year because of this, Fundstrat's Tom Lee says.
A stock market rally is coming, but it may not last as long as you think, argues Allianz Global Investors' top strategist.
CNBC's Mike Santoli explains why the Fed seems intent on raising rates in June. Plus, a pure play on entertainment that may be a takeover target.
CNBC's Sharon Epperson interviews portfolio managers John Maloney, David Pearl and Nick Galluccio about their tech-stock picks.
Tuesday's rally appears to be tied to the battle over whether China's two mainland stock exchanges should be included in the world's biggest indexes.
Marketing software maker Marketo agrees to be bought out by Vista Equity Partners, a private equity firm based in San Francisco.
A judge ruled the fair value of the 2013 computer maker Dell buyout was $17.62 per share, entitling holdout stockholders to an added $3.87 per share.
Some of the names on the move ahead of the open.
Jim Cramer focused in on one stat during a light week of earnings that could change the Fed’s rate outlook.
Great Plains Energy, the parent of regulated utility Kansas City Power & Light, said it would buy rival Westar Energy for $8.6 billion.
Jazz Pharma will buy Celator Pharma, to gain access to an investigational product in development for treating acute myeloid leukemia.
Viacom's directors will fight any attempt to remove them from the media company's board, Director Fred Salerno said in a letter to shareholders.
Get the best of CNBC in your inbox